ISSN: 1389-9600

Journal Home

Journal Guideline

Familial Cancer Q2 Unclaimed

Springer Netherlands Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Familial Cancer is a journal indexed in SJR in Genetics and Oncology with an H index of 67. It has a price of 3190 €. It has an SJR impact factor of 1,016 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 1,016.

Familial Cancer focuses its scope in these topics and keywords: cancer, aspiration, breast, increased, nipple, women, risk, oxytocinassisted, history, highrisk, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q2) Genetics (Q2) Genetics (clinical) (Q2) Genetics (clinical) (Q2) Oncology (Q2)

Price

3190 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,016

SJR Impact factor

67

H Index

54

Total Docs (Last Year)

138

Total Docs (3 years)

1749

Total Refs

305

Total Cites (3 years)

131

Citable Docs (3 years)

2.28

Cites/Doc (2 years)

32.39

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Human Genetics Q2
Gene: X Q2
Advances in Biological Regulation Q2
Genes Chromosomes and Cancer Q2
Human Gene Therapy Q2

Compare this journals

Aims and Scope

Best articles by citations

Familial gastric cancer: update for practice management

Deranged Wnt signaling is frequent in hereditary nonpolyposis colorectal cancer

Barrett's esophagus in the patients with familial adenomatous polyposis

Ashkenazi Jewish genetic disorders

BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients

Differences of Onset Age and Survival Rates in Esophageal Squamous Cell Carcinoma Cases with and without Family History of Upper Gastrointestinal Cancer from a High-incidence Area in North China

Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy

Familial pancreatic carcinoma in Jews

A new frameshift MEN1 gene mutation associated with familial malignant insulinomas

Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge

Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics

A clinical perspective on genetic counseling and testing during end of life care for women with recurrent progressive ovarian cancer: opportunities and challenges

SHOW MORE ARTICLES

Nevoid basal cell carcinoma syndrome caused by splicing mutations in the PTCH1 gene

Foreword

What motivates interest in attending a familial cancer genetics clinic?

Association of APC I1307K and E1317Q polymorphisms with colorectal cancer among Egyptian subjects

Accuracy of BRCA1 and BRCA2 Founder Mutation Analysis in Formalin-Fixed and Paraffin-Embedded (FFPE) Tissue

Trends in colorectal cancer incidence and mortality in the Israeli Jewish ethnic populations

Haplotype analysis suggest that the MLH1 c.2059C>T mutation is a Swedish founder mutation

Concordant colon tumors in monozygotic twins previously treated for prostate cancer

Consumer awareness and attitudes about insurance discrimination post enactment of the Genetic Information Nondiscrimination Act

Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome)

Mutation analysis of the PALB2 cancer predisposition gene in familial melanoma

Vestibular schwannoma in a patient with neurofibromatosis type 1: clinical report and literature review